Preoperation chemotherapy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Oxaliplatin and irinotecan have widened the chemotherapy alternatives available to patients with metastatic colorectal cancer, and effective targeted agents have further improved treatment efficacy. Combinations of these drugs have set a new benchmark of survival at ∼20 months, enabling a substantial number of patients who were not candidates for resection to qualify for the procedure. Liver resection after tumor downsizing has yielded encouraging results, although cure is rarely achieved. Based on several theoretical advantages, preoperative chemotherapy is increasingly being used also in patients with resectable disease. However, the debate is still ongoing especially with respect to the oncologic benefits and the numerous drawbacks, including hepatic toxicity and the risk of inducing a complete radiologic response.

Original languageEnglish
Title of host publicationSurgical Treatment of Colorectal Liver Metastases
PublisherSpringer Milan
Pages75-100
Number of pages26
ISBN (Print)9788847018082
DOIs
Publication statusPublished - 2011

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Preoperation chemotherapy'. Together they form a unique fingerprint.

  • Cite this

    Aglietta, M. (2011). Preoperation chemotherapy. In Surgical Treatment of Colorectal Liver Metastases (pp. 75-100). Springer Milan. https://doi.org/10.1007/978-88-470-1809-9_6